SG11202108835SA - Bicyclic sulfonamides - Google Patents

Bicyclic sulfonamides

Info

Publication number
SG11202108835SA
SG11202108835SA SG11202108835SA SG11202108835SA SG11202108835SA SG 11202108835S A SG11202108835S A SG 11202108835SA SG 11202108835S A SG11202108835S A SG 11202108835SA SG 11202108835S A SG11202108835S A SG 11202108835SA SG 11202108835S A SG11202108835S A SG 11202108835SA
Authority
SG
Singapore
Prior art keywords
substituted
compound
pharmaceutically acceptable
acceptable salt
unsubstituted
Prior art date
Application number
SG11202108835SA
Other languages
English (en)
Inventor
Leonid Beigelman
David Bernard Smith
Original Assignee
Aligos Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aligos Therapeutics Inc filed Critical Aligos Therapeutics Inc
Publication of SG11202108835SA publication Critical patent/SG11202108835SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202108835SA 2019-02-14 2020-02-12 Bicyclic sulfonamides SG11202108835SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962805725P 2019-02-14 2019-02-14
PCT/US2020/017974 WO2020167984A1 (en) 2019-02-14 2020-02-12 Bicyclic sulfonamides

Publications (1)

Publication Number Publication Date
SG11202108835SA true SG11202108835SA (en) 2021-09-29

Family

ID=72045615

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108835SA SG11202108835SA (en) 2019-02-14 2020-02-12 Bicyclic sulfonamides

Country Status (13)

Country Link
US (1) US11033556B2 (cg-RX-API-DMAC7.html)
EP (1) EP3924357A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022519764A (cg-RX-API-DMAC7.html)
KR (1) KR20210126636A (cg-RX-API-DMAC7.html)
CN (1) CN113423712A (cg-RX-API-DMAC7.html)
AU (1) AU2020221839B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021015864A2 (cg-RX-API-DMAC7.html)
CA (1) CA3128061A1 (cg-RX-API-DMAC7.html)
IL (1) IL284940A (cg-RX-API-DMAC7.html)
MX (1) MX2021009717A (cg-RX-API-DMAC7.html)
SG (1) SG11202108835SA (cg-RX-API-DMAC7.html)
TW (1) TW202045516A (cg-RX-API-DMAC7.html)
WO (1) WO2020167984A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220024192A (ko) 2019-05-31 2022-03-03 알리고스 테라퓨틱스 인코포레이티드 변형된 갭머 올리고뉴클레오타이드 및 사용 방법
CN115160344A (zh) * 2021-04-06 2022-10-11 上海长森药业有限公司 通过口服给药抑制CD4+Treg细胞的药物和方法
KR20240099159A (ko) 2021-09-08 2024-06-28 알리고스 테라퓨틱스 인코포레이티드 변형된 짧은 간섭 핵산(sina) 분자 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10875876B2 (en) * 2015-07-02 2020-12-29 Janssen Sciences Ireland Uc Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
CN108264520B (zh) * 2017-01-03 2021-12-07 上海长森药业有限公司 用于治疗乙型肝炎的化合物及其用途
CN109251212A (zh) * 2017-07-14 2019-01-22 上海长森药业有限公司 内环硫醚酰胺-芳基酰胺类化合物及其治疗乙型肝炎的用途

Also Published As

Publication number Publication date
JP2022519764A (ja) 2022-03-24
TW202045516A (zh) 2020-12-16
AU2020221839B2 (en) 2024-09-12
KR20210126636A (ko) 2021-10-20
EP3924357A4 (en) 2023-02-22
WO2020167984A1 (en) 2020-08-20
CN113423712A (zh) 2021-09-21
MX2021009717A (es) 2021-09-14
US20200345749A1 (en) 2020-11-05
AU2020221839A1 (en) 2021-08-19
BR112021015864A2 (pt) 2021-10-05
IL284940A (en) 2021-09-30
US11033556B2 (en) 2021-06-15
CA3128061A1 (en) 2020-08-20
EP3924357A1 (en) 2021-12-22

Similar Documents

Publication Publication Date Title
US11771680B2 (en) Pyrrole compounds
TW201625658A (zh) 經取代之核苷、核苷酸及其類似物
US11033556B2 (en) Bicyclic sulfonamides
CA3195542A1 (en) Bicyclic compounds
AU2023257365A1 (en) Bicyclic compounds
HK40067770B (en) Pyrrole compounds
HK40067770A (en) Pyrrole compounds
WO2021030278A1 (en) Bicyclic compounds